Protein scientists could improve reproducibility and coordination across the field by rallying around a small, shared set of ...

The development of protein-protein interaction inhibitors is highly challenging, with only a limited number of successful cases to date. PRISM BioLab is tackling this demanding field by leveraging its ...

Hydrogen/deuterium exchange-mass spectrometry (HDX-MS) is a powerful technique for studying protein dynamics, however its widespread application has been constrained by high sample consumption and ...

The New York-based company, previously known as VantAI and incubated at Roivant before a spinoff, is working in a ...

If cells are the factories, proteins are the workers. They control nearly every aspect of cell function, from structure to signaling, from transport to defense. And, like many workers, they rarely act ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses ...

WEST LAFAYETTE, Ind. — The shared culprit in a slew of diseases — cancers, neurodegenerative diseases, diabetes — is molecules our cells have made incorrectly. Think of them as proteins gone wrong.

For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...